La Sala L, Prattichizzo F, Ceriello A
Reduce inflammation Chronic inflammation is thought to play a central role in the development of conditions like heart disease, cancer, and diabetes
Attie said the company plans to combine bimagrumab with other obesity meds, the next of which would be Zepbound, and that the drugs could be given separately or combined into one injection
Certain profiles warrant more careful monitoring: Patients with existing diabetic retinopathy, particularly those with a history of poor blood sugar control Patients who have been diagnosed with or are at risk for age-related macular degeneration Those with hypertension, high cholesterol, or obstructive sleep apnea Patients with a small cup-to-disc ratio, which can only be assessed during a dilated eye exam Those starting semaglutide specifically, given its stronger association with both NAION and diabetic retinopathy compared to tirzepatide Knowing your individual risk profile before starting therapy, not after a vision change occurs, is the most effective approach
